Yoel Toledano
Overview
Explore the profile of Yoel Toledano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Messika A, Toledano Y, Hadar E, Tauman R, Froy O, Shamir R
Nutrients
. 2025 Jan;
17(1.
PMID: 39796591
Background/objectives: Studies have shown that chronobiological factors may adversely affect glycemic control in patients with type 2 diabetes mellitus. We assessed the association of chronobiological factors with glycemic control and...
2.
Tarashandegan D, Naeh A, Hallak M, Toledano Y, Gabbay-Benziv R, Maor-Sagie E
Am J Perinatol
. 2024 Nov;
PMID: 39608760
Objective: This study aimed to evaluate the risk of type 2 diabetes mellitus (T2DM) in women with flat response in the 100-g oral glucose tolerance test (OGTT) performed during pregnancy...
3.
Cohen N, Toledano Y, Shafir M, Lavie O, Zilberlicht A
Arch Gynecol Obstet
. 2024 Nov;
310(6):3029-3035.
PMID: 39607441
Purpose: To assess the postpartum sensitivity and accuracy of serum HbA1c levels, compared to the gold standard of 75-g Oral Glucose Tolerance Test (OGTT), for diagnosis of dysglycemia in patients...
4.
Maor-Sagie E, Hallak M, Haggiag N, Naeh A, Toledano Y, Gabbay-Benziv R
Diabetes Res Clin Pract
. 2024 Jul;
214:111782.
PMID: 39002931
Aim: To evaluate and compare the risk of progressing to type 2 diabetes (T2DM) based on the timing of gestational diabetes (GDM) diagnosis during pregnancy. Methods: Retrospective analysis of pregnant...
5.
Haggiag N, Rotman M, Hallak M, Toledano Y, Gabbay-Benziv R, Maor-Sagie E
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999372
: To evaluate the risk of progression to type 2 diabetes (T2D) following reactive hypoglycemia in 100 g oral glucose tolerance test (oGTT): A retrospective analysis of parturients with up...
6.
Maor-Sagie E, Hallak M, Twig G, Toledano Y, Gabbay-Benziv R
Int J Gynaecol Obstet
. 2024 Jun;
167(2):728-735.
PMID: 38864262
Objective: Impaired fasting glucose is a prediabetic condition defined as glucose levels of 100-125 mg/dL and is considered a risk factor for type 2 diabetes. However, this definition does not...
7.
Hussein-Aro R, Maor-Sagie E, Toledano Y, Hallak M, Gabbay-Benziv R
Diabetes Res Clin Pract
. 2024 Apr;
211:111659.
PMID: 38609019
Objectives: To evaluate the risk of type 2 diabetes(T2D) following one abnormal value(OAbV) in an oral glucose tolerance test(oGTT) performed during pregnancy. Study Design: A retrospective analysis of parturients between...
8.
Naeh A, Maor-Sagie E, Hallak M, Toledano Y, Gabbay-Benziv R
Am J Obstet Gynecol
. 2024 Feb;
231(2):259.e1-259.e10.
PMID: 38360449
Background: The relationship between gestational diabetes mellitus and adverse outcomes in multifetal pregnancies is complex and controversial. Moreover, limited research has focused on the risk of gestational diabetes mellitus progression...
9.
Maor-Sagie E, Hallak M, Toledano Y, Gabbay-Benziv R
J Clin Med
. 2023 Sep;
12(18).
PMID: 37763012
Gestational diabetes mellitus (GDM) is diagnosed by an oral glucose tolerance test (oGTT), preferably performed at 24 + 0-28 + 6 gestational weeks, and is considered a risk factor for...
10.
Ovadia Y, Gefel D, Toledano Y, Rosen S, Avrahami-Benyounes Y, Groisman L, et al.
Nutrients
. 2023 Jul;
15(13).
PMID: 37447240
It is unclear how maternal glycemic status and maternal iodine status influence birth weight among individuals with mild-to-moderate iodine deficiency (ID). We studied the association between birth weight and both...